Navigating the Future of Diagnostic Testing by Yuriy Shevchenko, PhD
Home > About Us > News & Events > Navigating the Future of Diagnostic Testing by Yuriy Shevchenko, PhD
Navigating the Future of Diagnostic Testing by Yuriy Shevchenko, PhD
September 27, 2024
“The diagnostic testing industry stands at a crossroads, shaped by past experiences and future aspirations. As we navigate this complex landscape, it’s crucial to learn from the past, address current challenges, and seize opportunities for innovation.
Novel diagnostic product developers, the FDA, and other regulators must strike a balance now that permits continued innovation while ensuring that all these ground-breaking tools are sufficiently well-validated to deliver on their promises. Using translation services that ensure labs and the FDA communicate effectively will help achieve this balance.”
Read more from Yuriy Shevchenko, PhD, SME and Expert Consultant in our full lifecycle Clinical Laboratory LIMS, Automation, and Bioinformatics practice in this article via Ad Astra, Inc.
Yuriy is available to help labs with all of their needs operationalizing lab workflows, moving from R&D to commercial launch, improving assay designs, reducing TAT, automating, and reducing failures. You can find out more about Yuriy on our website via the link below. And if you’d like to find out how Yuriy and Leap Consulting Group can help your organization with LIMS, Bioinformatics, or Lab Automation, contact us.